At a glance
ClinicalIndex Comparison RecordN/AActive· 40 target
Drug / intervention
Wearable Activity Monitorother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
NCT04575402N/AActiveUpdate OverdueUpdated 22mo ago · Completion was 18mo agoEnrollment Stalled
Evaluating the Role of Wearable Technology and Patient-reported Outcomes to Monitor Physical Function Decline in Prostate Cancer Survivors
In Brief
An observational study evaluating Wearable Activity Monitor for Prostate Cancer. Active but no longer recruiting, targeting 40 participants across 1 site.
Signals
Enrollment appears stalled
Detailed Summary
Prospective observational research study to evaluate the role of wearable activity monitors to predict physical function decline among prostate cancer survivors receiving ADT.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsProstate Cancer
CountriesUnited States
CollaboratorsUnited States Department of Defense
Timeline
N/AActiveOverdue
202120222023202420252026
First PostedOct 2020
Enrollment StartFeb 2021
Primary CompletionDec 2024
TodayJul 2026
First PostedOct 5, 2020
Enrollment StartFeb 19, 2021
Primary CompletionDec 31, 2024
TodayJul 2, 2026
Enrollment to primary: 3.9 yearsPosted 5.7 years ago
Interventions
Wearable Activity Monitorother
Continuous monitoring of physical activity including step counts, sleep, heart rate, with consumer-based wearable activity monitor (Fitbit Charge HR4 or similar model)